AstraZeneca’s Klygefa Approved in US for Adult gMG Treatment
The approval was supported by PREVAIL Phase III results showing statistically significant results; the body text is truncated.
The approval was supported by PREVAIL Phase III results showing statistically significant results; the body text is truncated.